Microvascular dysfunction: a potential pathophysiological role in the metabolic syndrome.
about
Muscle perfusion: its measurement and role in metabolic regulationTranscriptome-wide RNA sequencing analysis of rat skeletal muscle feed arteries. I. Impact of obesityInsulin Enhances Endothelial Function Throughout the Arterial Tree in Healthy But Not Metabolic Syndrome Subjects.Heart of the matter: coronary dysfunction in metabolic syndrome.Losartan increases muscle insulin delivery and rescues insulin's metabolic action during lipid infusion via microvascular recruitment.Insulin regulates its own delivery to skeletal muscle by feed-forward actions on the vasculature.Treatment of hypertension in obese patients.The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin actionImpaired microvascular perfusion: a consequence of vascular dysfunction and a potential cause of insulin resistance in muscle.Thrombophilia mediates lowering cardiovascular risk factors in women with a history of preeclampsia.Associations among metabolic syndrome, ischemia, inflammatory, oxidatives, and lipids biomarkersImpairment of skin blood flow during post-occlusive reactive hyperhemy assessed by laser Doppler flowmetry correlates with renal resistive index.Is pulse pressure a predictor of new-onset diabetes in high-risk hypertensive patients?: a subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trialMicrovascular function is preserved in newly diagnosed rheumatoid arthritis and low systemic inflammatory activity.Meal-related increases in microvascular vasomotion are impaired in obese individuals: a potential mechanism in the pathogenesis of obesity-related insulin resistance.Impaired microvascular properties in uncomplicated type 1 diabetes identified by Doppler ultrasound of the ocular circulation.Repeatability of the evaluation of systemic microvascular endothelial function using laser doppler perfusion monitoring: clinical and statistical implications.Retinal vascular caliber and the development of hypertension: a meta-analysis of individual participant data.Endothelial nitric oxide synthase transgenic models of endothelial dysfunctionInsulin's microvascular vasodilatory effects are inversely related to peripheral vascular resistance in overweight, but insulin-sensitive subjects.Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study.Effects of dietary creatine supplementation on systemic microvascular density and reactivity in healthy young adultsAssessment of left and right ventricular diastolic and systolic functions using two-dimensional speckle-tracking echocardiography in patients with coronary slow-flow phenomenonEffects of Incretin-Based Therapies on Neuro-Cardiovascular Dynamic Changes Induced by High Fat Diet in Ratsα-Tocopherol Improves Microcirculatory Dysfunction on Fructose Fed HamstersAlterations in skin microvascular function in patients with rheumatoid arthritis and ankylosing spondylitis.Bubble-Induced Endothelial Microparticles Promote Endothelial Dysfunction.Perivascular adipose tissue control of insulin-induced vasoreactivity in muscle is impaired in db/db miceCardiovascular risk factors and incident Alzheimer disease: a systematic review of the literature.eNOS, metabolic syndrome and cardiovascular disease.Human endothelial function and microvascular ageing.Incidence and predictors of stroke during the index event in an ethnically diverse Takotsubo cardiomyopathy population.Impaired function of coronary BK(Ca) channels in metabolic syndromeInvasive minimal Microvascular Resistance Is a New Index to Assess Microcirculatory Function Independent of Obstructive Coronary Artery Disease.Metabolic syndrome components and their response to lifestyle and metformin interventions are associated with differences in diabetes risk in persons with impaired glucose tolerance.Microvascular dysfunction: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension.Cardiovascular risk in the young type 1 diabetes population with a low 10-year, but high lifetime risk of cardiovascular disease.Microvascular dysfunction: an emerging pathway in the pathogenesis of obesity-related insulin resistance.Graft microvascular disease in solid organ transplantation.Ageing and microvasculature.
P2860
Q27026527-9C2DBF03-E02D-4617-B9B5-1D26FB5290BDQ28386749-7D92CB40-9D91-46AE-B41A-1FBA509793FDQ30277770-B7DBF4F5-2DDA-4FCA-80D7-872E702134F3Q30404992-35A03666-C8C9-426A-8FE0-1E4E14912022Q30414452-1BB8ACF0-DAE3-46AB-A5A8-F25DA5C935C6Q30425679-F05EF7F9-180E-488F-A450-56908FE08BEDQ30429298-D99839C5-0538-4017-855D-12B56A1D0165Q30436236-D2EB0F1F-5413-4E3A-8724-4EA06F0646D4Q30438252-0B43A2E8-9B69-48A6-A080-115E74270C92Q33699211-4EA6E8B5-3E31-4C68-A318-9C7B1E023F1CQ33736191-F33D000E-E8E0-4AC9-87BC-BF87872568AFQ33797620-3D5599B7-E00C-4093-BF8F-83F8B79F97B5Q33804718-90260466-8F7B-486F-8D4C-B54AED813C57Q33869938-B7DEB5F3-8A5C-4D32-9918-7BB9235238CAQ33883164-571855FE-AAB4-4D21-AC71-CD9BDFB7E534Q33926623-63A42381-F04A-4DF0-B960-3873045FB9EFQ33927530-982493EE-D4C7-4343-AC87-15B6C7B4D182Q33997295-F07429F8-5B6A-4436-AD52-A1B969410818Q34286604-5EADA089-7F9A-43ED-8666-F649719BFF50Q34628166-BDF0600A-682B-4EE9-A627-FAEBAA2F75B5Q34776021-B524F069-8074-4FC7-9089-FE305B30EDCBQ34778540-F87E3502-5AFF-4210-BEC7-F127F61462CDQ35112494-83C18FEE-6756-48BC-8E08-35ECD2DFE9C4Q35909469-7E20F8AC-3393-42FF-864E-B2E8734D3FCBQ35921633-A4B88402-A17D-4262-9D7D-90A69EC0D9F8Q36182763-34327E4C-7030-4A08-AB2E-A17AEBC43D37Q36257626-822C46AA-6E97-4097-84E6-D607A3C4826BQ36560523-07916959-4091-4B64-82D0-4136D26E2039Q36946413-E6A8A963-7017-459E-A5F7-4BB87B8B10E7Q37317509-E713D507-F57C-4F5A-A391-82455E77A550Q37337816-2373292C-06C3-458B-AF90-C792D389DA2CQ37422850-FDAF3A5B-5C91-4655-8DA3-777C6998D610Q37430986-134A81A7-CBD9-464A-A4BA-57B86549ED3EQ37556287-A5700198-4A8D-4855-87A5-92149FD92EA5Q37619545-6133ECDF-B847-4081-B070-A61D59B0CA61Q37924914-A1F7A137-741E-4C2C-B6B5-1A6D44F5E6D0Q38045458-882827BB-6A57-43CB-B490-763F0B82C31AQ38072622-2D887DD8-8A7C-4ED8-B30B-FA45C0F76445Q38216381-0BAFCA99-13B4-431D-9949-A04E2B1D9ABEQ38253051-A74AB80D-983C-4781-A9FB-742226BDBDD6
P2860
Microvascular dysfunction: a potential pathophysiological role in the metabolic syndrome.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Microvascular dysfunction: a potential pathophysiological role in the metabolic syndrome.
@ast
Microvascular dysfunction: a potential pathophysiological role in the metabolic syndrome.
@en
type
label
Microvascular dysfunction: a potential pathophysiological role in the metabolic syndrome.
@ast
Microvascular dysfunction: a potential pathophysiological role in the metabolic syndrome.
@en
prefLabel
Microvascular dysfunction: a potential pathophysiological role in the metabolic syndrome.
@ast
Microvascular dysfunction: a potential pathophysiological role in the metabolic syndrome.
@en
P2093
P1433
P1476
Microvascular dysfunction: a potential pathophysiological role in the metabolic syndrome.
@en
P2093
Erik H Serné
Etto C Eringa
Renate T de Jongh
Richard G IJzerman
P304
P356
10.1161/HYPERTENSIONAHA.107.089680
P407
P577
2007-04-30T00:00:00Z